Integral Diagnostics (IDX) Stock Price, News & Analysis

Company Overview

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 240,828 shs
• Average Volume: N/A
• Market Capitalization: A$1.10 billion
• P/E Ratio: N/A
• Dividend Yield: 1.95%
• Price Target: N/A
• Consensus Rating: N/A

IDX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Integral Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Integral Diagnostics investors own include electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Credit Suisse Group (CS), Chimerix (CMRX), Capricor Therapeutics (CAPR) and Bathurst Resources (BRL).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: ASX:IDX
• CIK: N/A
• Web: www.integraldiagnostics.com.au
• Phone: 61 3 5339 0704
• Fax: N/A
• Employees: 2,010
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.26)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 1.39
• Net Income: -A$60.70 million
• Net Margins: -12.92%
• Pretax Margin: N/A
• Return on Equity: -20.16%
• Return on Assets: 3.36%

Debt

• Debt-to-Equity Ratio: 118.59
• Current Ratio: 0.86
• Quick Ratio: 1.84

Sales & Book Value

• Annual Sales: A$469.70 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 23.99
• Book Value: A$1.29 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 233,960,000
• Free Float: N/A
• Market Cap: A$1.10 billion
• Optionable: Not Optionable
• Beta: 0.73